If you'd invested in United Therapeutics (UTHR): performance and returns
Looking for United Therapeutics's share price history and how much the stock has returned? Here's its year-by-year performance and what $1,000 invested at different dates would be worth today.
💰 Calculator: how much would United Therapeutics have returned?
This calculator shows how much United Therapeutics stock would have returned based on the amount invested and the starting year. Pick a sum and a year and you'll instantly see what it would be worth today and the total gain. Real prices, excluding dividends.
If I'd invested $1,000 in United Therapeutics
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,536 | +54% |
| 3 years ago | $1,948 | +95% |
| 5 years ago | $3,570 | +257% |
| 10 years ago | $3,460 | +246% |
| since inception (1999) | $59,176 | +5818% |
Return by year (United Therapeutics)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +11% | $1,112 (+11%) |
| 2025 | +38% | $1,536 (+54%) |
| 2024 | +60% | $2,464 (+146%) |
| 2023 | -21% | $1,948 (+95%) |
| 2022 | +29% | $2,508 (+151%) |
| 2021 | +42% | $3,570 (+257%) |
| 2020 | +72% | $6,152 (+515%) |
| 2019 | -19% | $4,975 (+398%) |
| 2018 | -26% | $3,662 (+266%) |
| 2017 | +3% | $3,778 (+278%) |
| 2016 | -8% | $3,460 (+246%) |
Frequently asked questions
How much does UTHR return?
$1,000 invested in United Therapeutics 10 years ago would be worth $3,460 today, i.e. +13%/yr on average (price, excluding dividends).
What was UTHR's best/worst year?
Best year: 2020 (+72%). Worst year: 2018 (-26%). Year-by-year detail is above.
How much would $1,000 invested in UTHR since inception be worth?
Since 1999, $1,000 would have become $59,176 (+5818%). Past performance is not a guarantee.
Do United Therapeutics's returns include dividends?
No — these returns are price-only. If United Therapeutics pays a dividend, its total return would be somewhat higher — see its dividend page.
What is United Therapeutics's average annual return (ROI)?
United Therapeutics's return on investment is about +13%/yr over 10 years (price, excluding dividends), versus the S&P 500's ~10%/yr over the long run.